1887
Research Open Access
Like 0

Abstract

BACKGROUND

Chagas disease (CD), a tropical parasitic disease caused by , is increasingly recognised as a public health concern among Latin American migrants living in non-endemic settings. In London, United Kingdom (UK), home to over 160,000 people from endemic countries, no formal population-level CD screening programmes exist.

AIM

To investigate the seroepidemiology of CD infection in Latin American adults living in London, UK.

METHODS

A cross-sectional, observational study utilising questionnaires and serological () screening was performed between August 2023 and January 2025. Adults born in South America, Central America or Mexico (or whose mothers were born there) were eligible to participate. Screening was offered in primary care sites and by point-of-care serological testing at community events. Outcomes were seroprevalence, screening yield, positive predictive value of screening tests and linkage to care.

RESULTS

In primary care, of 2,739 eligible individuals offered screening, 276 (10.1%) accepted. At community events, 247 were screened. Of the 523 screened, 20 (3.8%) participants had positive screening tests, and CD was confirmed in 14 (2.7%), all born in Bolivia. Seroprevalence was lower in those screened in primary care (1.1%) than at community events (4.5%). The number needed to screen to detect one confirmed case (linked into care) was 37 overall, 92 in primary care and 22 at community events.

CONCLUSIONS

Screening for CD through primary care in the UK is highly challenging, with both low uptake and low yield amongst those tested. Targeted community-based outreach approaches result in higher screening yield and linkage to care.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.6.2500365
2026-02-12
2026-03-15
/content/10.2807/1560-7917.ES.2026.31.6.2500365
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/6/eurosurv-31-6-5.html?itemId=/content/10.2807/1560-7917.ES.2026.31.6.2500365&mimeType=html&fmt=ahah

References

  1. de Sousa AS, Vermeij D, Ramos AN Jr, Luquetti AO. Chagas disease. Lancet. 2024;403(10422):203-18.  https://doi.org/10.1016/S0140-6736(23)01787-7  PMID: 38071985 
  2. Ribeiro ALP, Machado Í, Cousin E, Perel P, Demacq C, Geissbühler Y, et al. The burden of Chagas disease in the contemporary World: The RAISE Study. Glob Heart. 2024;19(1):2.  https://doi.org/10.5334/gh.1280  PMID: 38222097 
  3. WHO. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015;90(6):33-43. PMID: 25671846 
  4. Coura JR, Viñas PA. Chagas disease: a new worldwide challenge. Nature. 2010;465(7301):S6-7.  https://doi.org/10.1038/nature09221  PMID: 20571554 
  5. Coura JR, Viñas PA, Junqueira AC. Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries. Mem Inst Oswaldo Cruz. 2014;109(7):856-62.  https://doi.org/10.1590/0074-0276140236  PMID: 25410988 
  6. Elkheir N, Carter J, García-Mingo A, Chiodini P. Chagas disease in non-endemic settings. BMJ. 2021;373(901):n901.  https://doi.org/10.1136/bmj.n901  PMID: 33837041 
  7. Elkheir N, Moore DAJ. Rare in the country, not in the community: Chagas disease in the Latin American diaspora. Lancet Microbe. 2024;5(10):100982.  https://doi.org/10.1016/j.lanmic.2024.100982  PMID: 39305918 
  8. Bayona-i-Carrasco J, Avila-Tàpies R. Latin Americans and Caribbeans in Europe: A Cross-Country Analysis. Int Migr. 2020;58(1):198-218.  https://doi.org/10.1111/imig.12565 
  9. International Organization for Migration (IOM). World Migration Report 2024. Grand-Saconnex; IOM. [Accessed: 2 Oct 2025]. Available from: https://publications.iom.int/books/world-migration-report-2024
  10. Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, et al. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16(37):19968.  https://doi.org/10.2807/ese.16.37.19968-en  PMID: 21944556 
  11. European Centre for Disease Prevention and Control (ECDC). A comprehensive systematic review for identifying the risk factors for carrying a Trypanosoma cruzi infection in non-endemic countries. Stockholm: ECDC. [Accessed: 30 Apr 2025]. Available from: https://www.ecdc.europa.eu/en/publications-data/comprehensive-systematic-review-identifying-risk-factors-carrying-trypanosoma
  12. Office for National Statistics (ONS). Census 2021 (England and Wales). ONS; 2021. Available from https://www.ons.gov.uk/search?topics=9731,6646,3845,9497,4262,4128,7755,4994,6885,9724,7367&filter=datasets
  13. Office for National Statistics (ONS). Live births (England and Wales). ONS;2021. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthsummarytablesenglandandwales/2021
  14. Requena-Méndez A, Moore DA, Subirà C, Muñoz J. Addressing the neglect: Chagas disease in London, UK. Lancet Glob Health. 2016;4(4):e231-3.  https://doi.org/10.1016/S2214-109X(16)00047-4  PMID: 27013306 
  15. UK Government Office for Health Improvement and Disparities (OHID). Chagas disease: migrant health guide. Advice and guidance on the health needs of migrant patients for healthcare practitioners. London: gov.uk; 2021. Available from: https://www.gov.uk/guidance/chagas-disease-migrant-health-guide
  16. The NHS Blood and Transplant (NHSBT) and the UK Health Security Agency. (UKHSA). Blood, tissue and organ donors: surveillance schemes. 2013. Available from: https://www.gov.uk/guidance/blood-tissue-and-organ-donors-surveillance-schemes
  17. Elkheir N, Sanchez Zelaya L, Valderrama Penagos L, Lopez L, Ville R, Sienra-Iracheta E, et al. Community-based serological screening for Chagas disease in London: a cross-sectional, observational pilot study. BMJ Public Health. 2025;3(2):e002940.
  18. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344-9.  https://doi.org/10.1016/j.jclinepi.2007.11.008  PMID: 18313558 
  19. Hartung C, Lerer A, Anokwa Y, Tseng C, Brunette W, Borriello G. Open data kit: tools to build information services for developing regions. Proceedings of the 4th ACM/IEEE International Conference on Information and Communication Technologies and Development; London, United Kingdom: Association for Computing Machinery; 2010. p. Article 18.
  20. Requena-Méndez A, Aldasoro E, de Lazzari E, Sicuri E, Brown M, Moore DA, et al. Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9(2):e0003540.  https://doi.org/10.1371/journal.pntd.0003540  PMID: 25680190 
  21. Nepomuceno de Andrade G, Bosch-Nicolau P, Nascimento BR, Martins-Melo FR, Perel P, Geissbühler Y, et al. Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis. Lancet Reg Health Eur. 2024;46:101040.  https://doi.org/10.1016/j.lanepe.2024.101040  PMID: 39290806 
  22. Gómez I Prat J, Essadek HO, Esperalba J, Serrat FZ, Guiu IC, Goterris L, et al. COVID-19: an opportunity of systematic integration for Chagas disease. Example of a community-based approach within the Bolivian population in Barcelona. BMC Infect Dis. 2022;22(1):298.  https://doi.org/10.1186/s12879-022-07305-6  PMID: 35346096 
  23. Silgado A, Bosch-Nicolau P, Sánchez-Montalvá A, Cervià A, Gomez-I-Prat J, Bagaria G, et al. Opportunistic community screening of chronic Chagas disease using a rapid diagnosis test in pharmacies in Barcelona (Catalonia, Spain): study protocol and pilot phase results. Int J Public Health. 2022;67:1605386.  https://doi.org/10.3389/ijph.2022.1605386  PMID: 36531607 
  24. Lescure FX, Paris L, Elghouzzi MH, Le Loup G, Develoux M, Touafek F, et al. [Experience of targeted screening of Chagas disease in Ile-de-France]. Bull Soc Pathol Exot. 2009;102(5):295-9. French. PMID: 20131423 
  25. Pane S, Giancola ML, Piselli P, Corpolongo A, Repetto E, Bellagamba R, et al. Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy. BMC Infect Dis. 2018;18(1):212.  https://doi.org/10.1186/s12879-018-3118-5  PMID: 29739357 
  26. Da Costa-Demaurex C, Cárdenas MT, Aparicio H, Bodenmann P, Genton B, D’Acremont V. Screening strategy for Chagas disease in a non-endemic country (Switzerland): a prospective evaluation. Swiss Med Wkly. 2019;149(1314):w20050.  https://doi.org/10.4414/smw.2019.20050  PMID: 30946480 
  27. Chappuis F, Mauris A, Holst M, Albajar-Vinas P, Jannin J, Luquetti AO, et al. Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland. J Clin Microbiol. 2010;48(8):2948-52.  https://doi.org/10.1128/JCM.00774-10  PMID: 20554821 
  28. Roca C, Pinazo MJ, López-Chejade P, Bayó J, Posada E, López-Solana J, et al. Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain. PLoS Negl Trop Dis. 2011;5(4):e1135.  https://doi.org/10.1371/journal.pntd.0001135  PMID: 21572511 
  29. Ramos JM, Ponce Y, Gallegos I, Flóres-Chávez M, Cañavate C, Gutiérrez F. Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia. Pathog Glob Health. 2012;106(2):102-6.  https://doi.org/10.1179/2047773212Y.0000000013  PMID: 22943545 
  30. Antinori S, Galimberti L, Grande R, Bianco R, Oreni L, Traversi L, et al. Chagas disease knocks on our door: a cross-sectional study among Latin American immigrants in Milan, Italy. Clin Microbiol Infect. 2018;24(12):1340.e1-6.  https://doi.org/10.1016/j.cmi.2018.03.017  PMID: 29555394 
  31. Ciftci Y, Blane DN. Improving GP registration and access for migrant health. Br J Gen Pract. 2022;72(715):56-7.  https://doi.org/10.3399/bjgp22X718301  PMID: 35091400 
/content/10.2807/1560-7917.ES.2026.31.6.2500365
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error